Identification of the Main Chemical constituents and mechanism of Renshen Guben oral liquid against Renal Fibrosis

• Main Authors: Junhong Zhang (Author), Juqin Peng (Author), Tong Zhang (Author), Hong Jiang (Author), Yuewen Qin (Author), Hong Chen (Author), Xiaofang Deng (Author), Junguo Ren (Author), Ping Wang (Author), Haiyu Xu (Author)
• Format: Book
• Published: BMC, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Renal fibrosis is the late stage of many chronic kidney diseases (CKD). Clinically, there is almost no effective treatment for renal fibrosis except dialysis. Renshen Guben oral liquid (RSGB) is a Chinese patent medicine approved by National Medical Products Administration (NMPA)...